Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Post by trenton55on Mar 18, 2021 12:47pm
156 Views
Post# 32826570

People can't handle delayed gratification

People can't handle delayed gratificationCompany is still undervalued currently sitting at a 30 mil market cap lol

People want instant results for a company that only recently became predominantly medical. Financials haven't even been released for this new medical company yet. The foundation basically began producing revenue in Q4 and started picking up this Q1. Everyone is panicking and ignoring the fact this company is fresh and barely established. They seem to be working fast to build a future for it. We know it's undervalued but there's no concrete financial report indicating that, which is the first thing a lot of people look for before they even consider investing.

The panic selling is mostly from newbie retail investors because this stock was pumped up on reddit around GME phase 1. Lots of noobs bought in and that resulted in a panic sell domino effect when they realized they won't get instantly rich like some people did off GME. We live in a world of instant gratification.
<< Previous
Bullboard Posts
Next >>